Michio Shimabukuro


Ontology type: schema:Person     


Person Info

NAME

Michio

SURNAME

Shimabukuro

Publications in SciGraph latest 50 shown

  • 2022-11-15 Loss of participation among evacuees aged 20–37 years in the disaster cohort study after the Great East Japan Earthquake in SCIENTIFIC REPORTS
  • 2022-10-03 Hematological parameters of anemia and prognosis of non-dialysis-dependent chronic kidney disease: the Fukushima CKD cohort study in CLINICAL AND EXPERIMENTAL NEPHROLOGY
  • 2022-08-08 Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial in CARDIOVASCULAR DIABETOLOGY
  • 2022-06-28 Impact of lifestyle and psychosocial factors on the onset of hypertension after the Great East Japan earthquake: a 7-year follow-up of the Fukushima Health Management Survey in HYPERTENSION RESEARCH
  • 2022-06-25 Changes in the proportion of anemia among young women after the Great East Japan Earthquake: the Fukushima health management survey in SCIENTIFIC REPORTS
  • 2022-06-22 Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial in CLINICAL RESEARCH IN CARDIOLOGY
  • 2021-12-07 Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity in DIABETOLOGY INTERNATIONAL
  • 2021-11-26 Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity in DIABETOLOGY INTERNATIONAL
  • 2021-11-08 Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity in DIABETOLOGY INTERNATIONAL
  • 2021-10-17 Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study in HYPERTENSION RESEARCH
  • 2021-07-31 Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin in CARDIOVASCULAR DIABETOLOGY
  • 2021-06-28 Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial in CARDIOVASCULAR DIABETOLOGY
  • 2021-06-03 High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes in SCIENTIFIC REPORTS
  • 2021-02-03 Novel STAR gene variant in a patient with classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency in HUMAN GENOME VARIATION
  • 2021-01-14 Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease in SCIENTIFIC REPORTS
  • 2021-01-12 Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population in SCIENTIFIC REPORTS
  • 2021-01-07 Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study in CLINICAL AND EXPERIMENTAL NEPHROLOGY
  • 2020-06-15 Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy in CARDIOVASCULAR DIABETOLOGY
  • 2020-06-13 Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial in CARDIOVASCULAR DIABETOLOGY
  • 2020-02-21 Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial in SCIENTIFIC REPORTS
  • 2019-12-26 Blood pressure control in chronic kidney disease according to underlying renal disease: the Fukushima CKD cohort in CLINICAL AND EXPERIMENTAL NEPHROLOGY
  • 2019-12-03 Comparison of the prognostic values of three calculation methods for echocardiographic relative wall thickness in acute decompensated heart failure in CARDIOVASCULAR ULTRASOUND
  • 2019-11-16 Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial in CARDIOVASCULAR DIABETOLOGY
  • 2019-09-10 Metabolically and immunologically beneficial impact of extra virgin olive and flaxseed oils on composition of gut microbiota in mice in EUROPEAN JOURNAL OF NUTRITION
  • 2019-08-01 Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice in SCIENTIFIC REPORTS
  • 2019-06-12 Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial in SCIENTIFIC REPORTS
  • 2019-06-03 Fast eating is a strong risk factor for new-onset diabetes among the Japanese general population in SCIENTIFIC REPORTS
  • 2019-02-26 New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population in SCIENTIFIC REPORTS
  • 2018-11-08 Protective effect of remifentanil on blood loss in endoscopic subcutaneous mastectomy: a retrospective study in AIN-SHAMS JOURNAL OF ANESTHESIOLOGY
  • 2018-09-17 Low fasting plasma glucose level as a predictor of new-onset diabetes mellitus on a large cohort from a Japanese general population in SCIENTIFIC REPORTS
  • 2018-02-12 Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial in CARDIOVASCULAR DRUGS AND THERAPY
  • 2017-11-28 Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus in ADVANCES IN THERAPY
  • 2017-10-04 Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus in DIABETOLOGY & METABOLIC SYNDROME
  • 2017-07-06 α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study in CARDIOVASCULAR DIABETOLOGY
  • 2017-04-12 Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial in CARDIOVASCULAR DIABETOLOGY
  • 2016-09-13 Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study in CARDIOVASCULAR DIABETOLOGY
  • 2016-05-17 Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men in CARDIOVASCULAR DIABETOLOGY
  • 2015-12-01 Erratum to: ‘Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome’ in NUTRITION JOURNAL
  • 2015-10-29 Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome in NUTRITION JOURNAL
  • 2014-12-04 Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease in NUTRITION JOURNAL
  • 2014-02-26 Association of lower limb muscle mass and energy expenditure with visceral fat mass in healthy men in DIABETOLOGY & METABOLIC SYNDROME
  • 2014-01-31 Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice in CARDIOVASCULAR DIABETOLOGY
  • 2013-08-27 Pentraxin 3 is a local inflammatory marker in atrial fibrillation in HEART AND VESSELS
  • 2013-03-15 Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 protein in HEART AND VESSELS
  • 2012-11-08 Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice in CARDIOVASCULAR DIABETOLOGY
  • 2012-09-10 Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in Japanese subjects in CARDIOVASCULAR DIABETOLOGY
  • 2012-07 [Endothelial dysfunction]. in SPRINGERREFERENCE
  • 2002-11-12 Identification of three new mutations of the HNF-1α gene in Japanese MODY families in DIABETOLOGIA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.411582.b", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267313.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.136593.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267625.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.460111.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413450.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26999.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8591.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267335.6", 
            "type": "Organization"
          }
        ], 
        "familyName": "Shimabukuro", 
        "givenName": "Michio", 
        "id": "sg:person.01233731752.49", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0001-7835-7665"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233731752.49", 
          "https://orcid.org/0000-0001-7835-7665"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-12-01T07:13", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/person/person_739.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01233731752.49'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01233731752.49'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01233731752.49'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01233731752.49'


     

    This table displays all metadata directly associated to this object as RDF triples.

    37 TRIPLES      11 PREDICATES      21 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01233731752.49 schema:affiliation N64ea931f585b4922a90b0049da848b12
    2 grid-institutes:grid.136593.b
    3 grid-institutes:grid.267313.2
    4 grid-institutes:grid.267335.6
    5 grid-institutes:grid.267625.2
    6 grid-institutes:grid.26999.3d
    7 grid-institutes:grid.413450.7
    8 grid-institutes:grid.460111.3
    9 grid-institutes:grid.8591.5
    10 schema:familyName Shimabukuro
    11 schema:givenName Michio
    12 schema:identifier N7174e3e8ab6b45a0a717c2294ea0fa30
    13 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233731752.49
    14 https://orcid.org/0000-0001-7835-7665
    15 schema:sdDatePublished 2022-12-01T07:13
    16 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    17 schema:sdPublisher N9c8b375949eb4b48b91bd89613440efe
    18 sgo:license sg:explorer/license/
    19 sgo:sdDataset persons
    20 rdf:type schema:Person
    21 N64ea931f585b4922a90b0049da848b12 schema:affiliation grid-institutes:grid.411582.b
    22 sgo:isCurrent true
    23 rdf:type schema:OrganizationRole
    24 N7174e3e8ab6b45a0a717c2294ea0fa30 schema:name orcid_id
    25 schema:value 0000-0001-7835-7665
    26 rdf:type schema:PropertyValue
    27 N9c8b375949eb4b48b91bd89613440efe schema:name Springer Nature - SN SciGraph project
    28 rdf:type schema:Organization
    29 grid-institutes:grid.136593.b schema:Organization
    30 grid-institutes:grid.267313.2 schema:Organization
    31 grid-institutes:grid.267335.6 schema:Organization
    32 grid-institutes:grid.267625.2 schema:Organization
    33 grid-institutes:grid.26999.3d schema:Organization
    34 grid-institutes:grid.411582.b schema:Organization
    35 grid-institutes:grid.413450.7 schema:Organization
    36 grid-institutes:grid.460111.3 schema:Organization
    37 grid-institutes:grid.8591.5 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...